Abingworth LLP Nu Cana PLC Call Options Transaction History
Abingworth LLP
- $301 Million
- Q4 2022
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NCNA
# of Institutions
2Shares Held
3.34MCall Options Held
0Put Options Held
0About NuCana plc
- Ticker NCNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,196,000
- Market Cap $83.5M
- Description
- NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients ...